Galantamine for the treatment of BPSD in Thai patients with possible Alzheimer's disease with or without cerebrovascular disease

Galantamine for the treatment of BPSD in Thai patients with possible Alzheimer's disease with or without cerebrovascular disease

Objectives. This study was to investigate an efficacy of galantamine in treatment of behavioral and psychological symptoms of dementia in Thai elderly who suffered from possible Alzheimer's disease (AD) with or without cerebrovascular disease and vascular dementia. Methods. A 6-month, multicent...

Saved in:

書目詳細資料
Main Authors:	S. Tangwongchai, N. Thavichachart, V. Senanarong, N. Poungvarin, K. Phanthumchinda, R. Praditsuwan, S. Nidhinandana, S. Chankrachang
格式:	雜誌
出版:	2018
主題:	Medicine Neuroscience Psychology
在線閱讀:	https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=58149201395&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/49418
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!

相似書籍

Galantamine for the treatment of BPSD in Thai patients with possible Alzheimer's disease with or without cerebrovascular disease
由: S. Tangwongchai, et al.
出版: (2018)

Galantamine for the treatment of BPSD in Thai patients with possible Alzheimer's disease with or without cerebrovascular disease
由: S. Tangwongchai, et al.
出版: (2018)

Safety and tolerability of galantamine in possible Alzheimer's disease with or without cerebrovascular disease and vascular dementia in Thai patients.
由: Vorapun Senanarong, et al.
出版: (2018)

Efficacy study of galantamine in possible Alzheimer's disease with or without cerebrovascular disease and vascular dementia in Thai patients: A slow-titration regimen
由: Nantika Thavichachart, et al.
出版: (2018)

Efficacy study of galantamine in possible Alzheimer's disease with or without cerebrovascular disease and vascular dementia in Thai patients: A slow-titration regimen
由: Nantika Thavichachart, et al.
出版: (2018)

The effect of Galantamine on sleep quality in Thai Alzheimer's disease patients
由: Chankrachang S., et al.
出版: (2014)

The effect of Galantamine on sleep quality in Thai Alzheimer's disease patients
由: Siwaporn Chankrachang, et al.
出版: (2018)

The effect of Galantamine on sleep quality in Thai Alzheimer's disease patients
由: Siwaporn Chankrachang, et al.
出版: (2018)

Cerebral white matter disease is independently associated with BPSD in Alzheimer's disease
由: Kandiah, N., et al.
出版: (2016)

Priorities for research consortia on Alzheimer's disease
由: Serge Gauthier, et al.
出版: (2018)

Alzheimer's disease with cerebrovascular disease: current status in the Asia–Pacific region
由: C. Chen, et al.
出版: (2018)

The platelet amyloid precursor protein ratio as a diagnostic marker for Alzheimer's disease in Thai patients
由: Chatchawan Srisawat, et al.
出版: (2018)

Agitation in alzheimer's disease is a manifestation of frontal lobe dysfunction
由: V. Senanarong, et al.
出版: (2018)

Alzheimers disease dementia as the diagnosis best supported by the cerebrospinal fluid biomarkers: Difference in cut-off levels from Thai experience
由: V. Senanarong, et al.
出版: (2018)

Distinct white matter microstructural abnormalities and extracellular water increases relate to cognitive impairment in Alzheimer's disease with and without cerebrovascular disease
由: Ji F., et al.
出版: (2020)

Identification of a novel mutation in APP gene in a thai subject with early-onset Alzheimer’s disease
由: Vo Van Giau, et al.
出版: (2019)

Gender differences in white matter pathology and mitochondrial dysfunction in Alzheimer's disease with cerebrovascular disease
由: Gallart-Palau X., et al.
出版: (2018)

Gender differences in white matter pathology and mitochondrial dysfunction in Alzheimer’s disease with cerebrovascular disease
由: Gallart-Palau, Xavier, et al.
出版: (2018)

The multi-faceted impact of methamphetamine on Alzheimer's disease: From a triggering role to a possible therapeutic use
由: Mayuri Shukla, et al.
出版: (2020)

Prophylactic botulinum type A toxin complex (Dysport®) for migraine without aura
由: Siwaporn Chankrachang, et al.
出版: (2018)

Prophylactic botulinum type A toxin complex (Dysport®) for migraine without aura
由: Siwaporn Chankrachang, et al.
出版: (2018)

Synaptic Plasticity and the Mechanism of Alzheimer's Disease
出版: (2017)

Accuracy of Support-Vector Machines for Diagnosis of Alzheimer's Disease, Using Volume of Brain Obtained by Structural MRI at Siriraj Hospital
由: Yudthaphon Vichianin, et al.
出版: (2022)

M2 microglia activation and proNGF inhibition : Possible Mechanisms Behind Cognitive Improvements by Low-Dose Ionizing Radiation on Alzheimer's Disease; A Literature Review
由: Alifa, Hasna Noor
出版: (2022)

Actions of the anti-angiogenic compound angiostatin in an animal model of Alzheimer's disease
由: Jae K. Ryu, et al.
出版: (2018)

Brain ureido degenerative protein modifications are associated with neuroinflammation and proteinopathy in Alzheimer’s disease with cerebrovascular disease
由: Gallart-Palau, Xavier, et al.
出版: (2018)

Serum Glycoproteomics and Identification of Potential Mechanisms Underlying Alzheimer's Disease
由: Naphatthakarn Kerdsaeng, et al.
出版: (2022)

A neuronal model of Alzheimer's disease: An insight into the mechanisms of oxidative stress-mediated mitochondrial injury
由: P. Sompol, et al.
出版: (2018)

Association between Gut Microbiota with Mild Cognitive Impairment and Alzheimer's Disease in a Thai Population
由: Wanapaisan P.
出版: (2023)

Cerebrovascular disease influences functional and structural network connectivity in patients with amnestic mild cognitive impairment and Alzheimer's disease
由: Vipin A., et al.
出版: (2020)

α-secretase in Alzheimer's disease and beyond: Mechanistic, regulation and function in the shedding of membrane proteins
由: Bruno Vincent, et al.
出版: (2018)

Hydroxychloroquine lowers Alzheimer's disease and related dementias risk and rescues molecular phenotypes related to Alzheimer's disease
由: Varma, Vijay RR, et al.
出版: (2023)

COVID-19 and cerebrovascular diseases: a comprehensive overview
由: Tsivgoulis, Georgios, et al.
出版: (2021)

Erratum to: Tackling challenges in care of Alzheimer's disease and other dementias amid the COVID-19 pandemic, now and in the future (Alzheimer's & Dementia, (2020), 16, 11, (1571-1581), 10.1002/alz.12143)
由: Vincent C.T. Mok, et al.
出版: (2022)

The neuroprotective effect of ethanolic extract Ocimum sanctum Linn. in the regulation of neuronal density in hippocampus areas as a central autobiography memory on the rat model of Alzheimer's disease
由: Mataram, M.B.A., et al.
出版: (2021)

Neurochemical basis for symptomatic treatment of Alzheimer's disease
由: Francis, Paul T, et al.
出版: (2021)

Treatment of dementia and mild cognitive impairment with or without cerebrovascular disease: Expert consensus on the use of Ginkgo biloba extract, EGb 761 ®
由: Kandiah, N, et al.
出版: (2020)

White matter disease: Early treatment of inflammatory demyelinating disease
由: Naraporn Prayoonwiwat, et al.
出版: (2018)

Melatonin protects against methamphetamine-induced Alzheimer's disease-like pathological changes in rat hippocampus
由: Pattama Panmak, et al.
出版: (2022)

Age and gender differences for the behavioral phenotypes of 3xTg alzheimer's disease mice
由: Tanita Pairojana, et al.
出版: (2022)